Current Management of Low Risk Differentiated Thyroid Cancer and Papillary Microcarcinoma. Issue 5 (May 2017)

• Record Type: Journal Article
• Authors: Tarasova, V.D.; Tuttle, R.M.
• Is Part Of: Clinical oncology. Volume 29:Issue 5(2017)
• Page Start: 290
• Page End: 297
• Publication Date: 2017-05
• Subjects: Low risk thyroid cancer -- papillary microcarcinoma -- staging; Oncology -- Periodicals; Tumors -- Periodicals; Cancer -- Treatment -- Periodicals; Radiotherapy -- Periodicals; Neoplasms -- Periodicals; Cancer -- Radiotherapy; Cancer -- Treatment; Oncology; Medical radiology; Radiotherapy; Tumors; Electronic journals; Periodicals; 616.994
• DOI: 10.1016/j.clon.2016.12.009
• Languages: English
• ISSNs: 0936-6555

Abstract

Abstract: Each year, the proportion of thyroid cancer patients presenting with low risk disease is increasing. Moreover, the definition of low risk thyroid cancer is expanding and several histological subtypes beyond papillary microcarcinomas are now classified as low risk disease. This shift in the landscape of thyroid cancer presentation is forcing clinicians to critically re-evaluate whether or not traditional management paradigms that were effective in treating intermediate and high risk disease are applicable to these low risk patients. Here we review the definition of low risk disease, examine the various histological subtypes that are considered low risk in the 2015 American Thyroid Association guidelines for the management of thyroid nodules and thyroid cancer, and review our current approach to the management of these low risk tumours.